The Mission

Building Infrastructure to
Turn Science into Companies.

97% of life sciences research never reaches patients — not because the science fails, but because the infrastructure around it does.

From Lab to Venture — Building the Infrastructure That Turns Science into Companies

IP strategy is misaligned with regulatory timelines. Clinical trials launch before safety systems exist. Leadership is hired at the wrong phase. Capital is deployed before the foundation is in place to use it.

The result is predictable: FDA delays, wasted capital, and breakthrough therapies that never reach the people who need them.

Zenphia was built to fix that. As institutional infrastructure for building biotechnology companies — the connective system between breakthrough science and the world that needs it.

97%

of life sciences research never reaches patients. This is the structural failure Zenphia was founded to solve by deploying execution infrastructure upstream.

Ready to Build the Right Way?

Join us in ensuring that breakthrough science reaches the communities who need it most.

Our ModelContact Us